NO971448D0 - Anti-Fas rekombinante antistoffer og DNA derfor - Google Patents
Anti-Fas rekombinante antistoffer og DNA derforInfo
- Publication number
- NO971448D0 NO971448D0 NO971448A NO971448A NO971448D0 NO 971448 D0 NO971448 D0 NO 971448D0 NO 971448 A NO971448 A NO 971448A NO 971448 A NO971448 A NO 971448A NO 971448 D0 NO971448 D0 NO 971448D0
- Authority
- NO
- Norway
- Prior art keywords
- fas
- dna
- recombinant antibodies
- recombinant
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7857096 | 1996-04-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO971448D0 true NO971448D0 (no) | 1997-03-26 |
NO971448L NO971448L (no) | 1997-10-02 |
Family
ID=13665565
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO971448A NO971448L (no) | 1996-04-01 | 1997-03-26 | Rekombinante anti-Fas-antistoffer og DNA for disse |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0799891A1 (no) |
KR (1) | KR100277769B1 (no) |
CN (1) | CN1167115A (no) |
AU (1) | AU724579B2 (no) |
CA (1) | CA2201185A1 (no) |
CZ (1) | CZ96397A3 (no) |
HU (1) | HUP9700676A3 (no) |
ID (1) | ID16796A (no) |
IL (1) | IL120553A0 (no) |
MX (1) | MX9702422A (no) |
NO (1) | NO971448L (no) |
NZ (1) | NZ314496A (no) |
ZA (1) | ZA972726B (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3331377B2 (ja) | 1994-11-30 | 2002-10-07 | 味の素株式会社 | 抗血栓剤及び抗フォンビルブランド因子モノクローナル抗体 |
AU736287B2 (en) * | 1997-03-21 | 2001-07-26 | Sankyo Company Limited | Humanized anti-human Fas antibody |
US6972323B1 (en) | 1997-04-01 | 2005-12-06 | Sankyo Company, Limited | Anti-Fas antibodies |
DE69938451T2 (de) | 1998-06-18 | 2009-04-09 | Imed Ab | Fas peptide und antikörper zur modulierung von apoptosis |
US20030114410A1 (en) | 2000-08-08 | 2003-06-19 | Technion Research And Development Foundation Ltd. | Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis |
ZA200900545B (en) * | 2006-07-18 | 2010-03-31 | Sanofi Aventis | Antagonist antibody against EPHA2 for the treatment of cancer |
IL184627A0 (en) | 2007-07-15 | 2008-12-29 | Technion Res & Dev Foundation | Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue |
CN105330743B (zh) * | 2007-08-02 | 2019-05-28 | 吉利德生物制剂公司 | Lox和loxl2抑制剂及其应用 |
WO2010080769A2 (en) | 2009-01-06 | 2010-07-15 | Arresto Biosciences, Inc. | Chemotherapeutic methods and compositions |
JP2013502226A (ja) | 2009-08-21 | 2013-01-24 | ギリアド バイオロジクス,インク. | リシル酸化酵素及びloxl2由来の触媒ドメイン |
KR101684246B1 (ko) | 2010-01-29 | 2016-12-08 | 가부시키가이샤 아크시스 | 변형성 관절증 치료제를 포함하는 주사제 |
CN105622757A (zh) | 2010-02-04 | 2016-06-01 | 吉联亚生物科技有限公司 | 结合赖氨酰氧化酶样2(loxl2)的抗体和其使用方法 |
CN111333720B (zh) * | 2020-03-16 | 2021-11-02 | 重庆理工大学 | 抗hpv16e7蛋白单抗79a11、杂交瘤细胞株及其制备方法和应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995010540A1 (en) * | 1993-10-14 | 1995-04-20 | Immunex Corporation | Fas antagonists and uses thereof |
WO1996040041A2 (en) * | 1995-06-07 | 1996-12-19 | Chiron Corporation | Antibodies to fas antigen capable of inhibiting apoptosis |
-
1997
- 1997-03-26 AU AU16552/97A patent/AU724579B2/en not_active Ceased
- 1997-03-26 NO NO971448A patent/NO971448L/no not_active Application Discontinuation
- 1997-03-27 ZA ZA9702726A patent/ZA972726B/xx unknown
- 1997-03-27 NZ NZ314496A patent/NZ314496A/xx unknown
- 1997-03-27 CA CA002201185A patent/CA2201185A1/en not_active Abandoned
- 1997-03-27 EP EP97302415A patent/EP0799891A1/en not_active Withdrawn
- 1997-03-28 CZ CZ97963A patent/CZ96397A3/cs unknown
- 1997-03-28 HU HU9700676A patent/HUP9700676A3/hu unknown
- 1997-03-30 IL IL12055397A patent/IL120553A0/xx unknown
- 1997-03-31 ID IDP971070A patent/ID16796A/id unknown
- 1997-04-01 CN CN97113457A patent/CN1167115A/zh active Pending
- 1997-04-01 KR KR1019970012033A patent/KR100277769B1/ko not_active IP Right Cessation
- 1997-04-01 MX MX9702422A patent/MX9702422A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU724579B2 (en) | 2000-09-28 |
NZ314496A (en) | 1999-02-25 |
KR970070198A (ko) | 1997-11-07 |
ID16796A (id) | 1997-11-13 |
MX9702422A (es) | 1998-03-31 |
CN1167115A (zh) | 1997-12-10 |
ZA972726B (en) | 1997-10-23 |
HUP9700676A3 (en) | 2001-02-28 |
EP0799891A1 (en) | 1997-10-08 |
AU1655297A (en) | 1997-10-09 |
HUP9700676A2 (hu) | 1998-01-28 |
CZ96397A3 (en) | 1997-10-15 |
CA2201185A1 (en) | 1997-10-01 |
KR100277769B1 (ko) | 2001-01-15 |
NO971448L (no) | 1997-10-02 |
HU9700676D0 (en) | 1997-05-28 |
IL120553A0 (en) | 1997-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS4496A (is) | Úðablöndur úr peptíðum og próteinum | |
NO20071415L (no) | OB-fusjonsproteinpreparater og fremgangsmater | |
NO2010013I1 (no) | Rekombinant FSH-CTP | |
IS5158A (is) | Genaraðgreinir og aðferðir | |
NO996551D0 (no) | Forbedrete anti-IgE-antistoffer og fremgangsmåte for forbedring av polypeptider | |
DE69724557D1 (de) | Dokumentenanalyse | |
IS1988B (is) | Interferon tengd efni | |
IS5375A (is) | KAY-nýstárlegt ónæmisprótín | |
DE69836432D1 (de) | Bildcoder und -decoder | |
NO985680L (no) | Peptidderivater | |
NO971448D0 (no) | Anti-Fas rekombinante antistoffer og DNA derfor | |
NO976058L (no) | Rekombinant mistellectin | |
NO983849D0 (no) | Peptidderivater | |
FI970168A (fi) | Peptidejä | |
DE69705017D1 (de) | Medikamente bindendes Protein | |
NO995062D0 (no) | <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som kodes for samme | |
DE69925271D1 (de) | Angiostatin-bindendes protein | |
TR199701666A3 (tr) | Sismanliga karsi proteinler | |
NO20005547D0 (no) | Myelinbasiske proteinpeptider og anvendelser derav | |
FR2744147B1 (fr) | Deversoir basculant | |
EP1142999A4 (en) | PROTEIN AND ITS DNA | |
EP1111047A4 (en) | NEW PROTEIN AND ITS DNA | |
NO20002832D0 (no) | Humantyroidprotein ZSig45 og DNA som koder for dette | |
NO20006091D0 (no) | Humant protein C-polypeptid | |
SE9602287D0 (sv) | Novel protein and methods for its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |